Clinical Trial Update: Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating acalabrutinib in combination with R-CHOP for previously untreated diffuse large B-cell lymphoma and is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Acalabrutinib (acalabrutinib)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING